Literature DB >> 9612358

Myocardial matrix metalloproteinase activity and abundance with congestive heart failure.

M L Coker1, C V Thomas, M J Clair, J W Hendrick, R S Krombach, Z S Galis, F G Spinale.   

Abstract

The left ventricular (LV) myocardial collagen matrix has been proposed to participate in the maintenance of LV geometry. Thus alterations in the composition of the LV myocardial collagen matrix may influence LV function. The matrix metalloproteinases (MMPs) are a family of enzymes that contribute to extracellular remodeling in several disease states. However, the types of MMPs expressed in the normal and congestive heart failure (CHF) state and the relation to MMP activity remained unclear. Accordingly, after 3 wk of pacing (240 beats/min), changes in LV function, substrate-specific MMP activity, and MMP subclass abundance were measured in comparison with control pigs (n = 6). Changes in LV function and geometry were measured by echocardiography; LV end-diastolic dimension increased (3.6 +/- 0.1 vs. 6.0 +/- 0.1 cm, P < 0.05) and LV fractional shortening decreased (47 +/- 1 vs. 15 +/- 1%, P < 0.05) compared with controls. Degradation of fibrillar collagen is achieved through the combined action of interstitial collagenase (MMP-1), gelatinase A (MMP-2), and stromelysin (MMP-3) (He, C., S. Wilheilm, A. Pentland, B. Marmer, G. Grant, A. Eisen, and G. Goldberg. Proc. Natl. Acad. Sci. USA 86:2632-2636, 1989; Woessner, J. FASEB J. 5: 2145-2154, 1991). Accordingly, the relative abundance of specific MMPs (MMP-1, MMP-2, and MMP-3) was examined by immunoblotting. With pacing CHF, the relative abundance for MMP-1 increased to 319 +/- 94%, MMP-2 increased to 194 +/- 31%, and MMP-3 increased to 493 +/- 159% (all P < 0.05). With pacing CHF, LV myocardial zymographic activity for the substrate gelatin increased by 119% (P < 0.05) and for the substrate collagen III by 153% (P < 0.05) over controls. Caseinolytic activity also increased with pacing CHF by 139% (P < 0.05) over controls. In conclusion, LV myocardial MMP activity and abundance increased with pacing-induced CHF. These findings demonstrate that pacing-induced CHF leads to changes in myocardial MMP activity and expression that may be responsible for LV remodeling in CHF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9612358     DOI: 10.1152/ajpheart.1998.274.5.H1516

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

Review 1.  The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.

Authors:  Alison J Kriegel; Yong Liu; Yi Fang; Xiaoqiang Ding; Mingyu Liang
Journal:  Physiol Genomics       Date:  2012-01-03       Impact factor: 3.107

2.  Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression.

Authors:  Elaine L Shelton; Katherine E Yutzey
Journal:  Dev Biol       Date:  2006-10-03       Impact factor: 3.582

Review 3.  Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.

Authors:  Shweta R Motiwala; Hanna K Gaggin
Journal:  Curr Heart Fail Rep       Date:  2016-10

4.  Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.

Authors:  Vikas Bhalla; Vasiliki V Georgiopoulou; Ali A Azeem; Catherine N Marti; Robert T Cole; Sonjoy R Laskar; Christine De Staercke; W Craig Hooper; Andrew L Smith; Andreas P Kalogeropoulos; Javed Butler
Journal:  Int J Cardiol       Date:  2011-07-01       Impact factor: 4.164

Review 5.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 6.  Genomics and the pathophysiology of heart failure.

Authors:  J J Hwang; V J Dzau; C C Liew
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

Review 7.  Mitochondria and cardiovascular diseases-from pathophysiology to treatment.

Authors:  Gerasimos Siasos; Vasiliki Tsigkou; Marinos Kosmopoulos; Dimosthenis Theodosiadis; Spyridon Simantiris; Nikoletta Maria Tagkou; Athina Tsimpiktsioglou; Panagiota K Stampouloglou; Evangelos Oikonomou; Konstantinos Mourouzis; Anastasios Philippou; Manolis Vavuranakis; Christodoulos Stefanadis; Dimitris Tousoulis; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

8.  Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.

Authors:  William M Yarbrough; Rupak Mukherjee; Robert E Stroud; Evan C Meyer; G Patricia Escobar; Jeffrey A Sample; Jennifer W Hendrick; Joseph T Mingoia; Francis G Spinale
Journal:  J Cardiovasc Pharmacol       Date:  2010-04       Impact factor: 3.105

Review 9.  Tachycardia-mediated cardiomyopathy: recognition and management.

Authors:  Rakesh Gopinathannair; Renee Sullivan; Brian Olshansky
Journal:  Curr Heart Fail Rep       Date:  2009-12

10.  Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction.

Authors:  Jennifer A Dixon; Robert C Gorman; Robert E Stroud; Shenikqua Bouges; Hamamoto Hirotsugu; Joseph H Gorman; Timothy P Martens; Silviu Itescu; Michael D Schuster; Theodore Plappert; Martin G St John-Sutton; Francis G Spinale
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.